Sustained Release Formulation of Primaquine for Prevention of Relapse of <i>Plasmodium vivax</i> Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study

<div>Disposition of study participants. PT: primaquine therapy, CT: chloroquine therapy, and MP: malarial parasite.</div>

Malaria Research and Treatment

fig1

Figure 1

Figure 1: Sustained Release Formulation of Primaquine for Prevention of Relapse of <i>Plasmodium vivax</i> Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study 

Figure 1 | Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study 